Results 31 to 40 of about 16,198,215 (212)

Opioid Use Disorders in People Living with HIV/AIDS: A Review of Implications for Patient Outcomes, Drug Interactions, and Neurocognitive Disorders

Pharmacy, 2020
The opioid epidemic has had a significant, negative impact in the United States, and people living with HIV/AIDS (PLWHA) represent a vulnerable sub-population that is at risk for negative sequela from prolonged opioid use or opioid use disorder (OUD ...
Alina Cernasev, Michael P. Veve, Theodore J. Cory, Nathan A. Summers, Madison Miller, Sunitha Kodidela, Santosh Kumar   +6 more
doaj   +1 more source

Analyzing opioid-use disorder websites in the United States: An optimized website usability study

Digital Health, 2022
Background As the United States continues to tackle the opioid epidemic, it is imperative for digital healthcare organizations to provide Internet users with accurate and accessible online resources so that they can make informed decisions with regards ...
Shuhan He, Saishravan Shyamsundar, Paul Chong, Jasmine Kannikal, Joshua Calvano, Neha Balapal, Nick Kallenberg, Adarsh Balaji, Amala Ankem, Alister Martin   +9 more
doaj   +1 more source

Opioid use disorder awareness [PDF]

, 2023
This project based off of objectives from Healthy People 2030 addressed awareness related to opioid use disorder (OUD) in the form of history of opioid epidemic, pathophysiology of opioid addiction, signs and symptoms of abuse and physiologic effects of ...
Carey, Yela
core  

Opioid use disorder and the brain: a clinical perspective.

, 2022
Opioid use disorder (OUD) has gained increasing publicity and interest during recent years, with many countries describing problems of epidemic proportions with regard to opioid use and deaths related to opioids.
Herlinger, Katherine, Lingford-Hughes, Anne   +1 more
core   +1 more source

Acute Pain and Development of Opioid Use Disorder: Patient Risk Factors. [PDF]

, 2023
PURPOSE OF REVIEW Pharmacological therapy for acute pain carries the risk of opioid misuse, with opioid use disorder (OUD) reaching epidemic proportions worldwide in recent years.
Filipovic, Mark Georg, Bello, Corina, Urman, Richard D, Luedi, Markus M, Baumann, Livia, Andereggen, Lukas   +5 more
core   +2 more sources

“A Lack of Empathy:” A qualitative study of Black people seeking treatment for opioid use disorder

SSM: Qualitative Research in Health, 2023
Racial inequities in the treatment of opioid use disorder (OUD) are an urgent and insidious issue, especially in the context of the national opioid overdose crisis.
Utsha G. Khatri, Max Jordan Nguemeni Tiako, Abeselom Gebreyesus, Andre Reid, Sara F. Jacoby, Eugenia C. South   +5 more
doaj   +1 more source

Primary care patients with moderate to severe opioid use disorder (OUD) symptoms: engagement in medication treatment for OUD [PDF]

Ann Fam Med, 2023
europepmc   +2 more sources

Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs

Addiction Science & Clinical Practice, 2021
Background Medications for opioid use disorder such as opioid agonist treatment (OAT, including methadone, buprenorphine) are the gold standard intervention for opioid use disorder (OUD).
Travis M. Scott, Julia Arnsten, James Patrick Olsen, Franchesca Arias, Chinazo O. Cunningham, Monica Rivera Mindt   +5 more
doaj   +1 more source

Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus. [PDF]

Addict Sci Clin Pract
Abstract Background The prevalence and associated overdose death rates from opioid use disorder (OUD) have dramatically increased in the last decade. Despite more available treatments than 20 years ago, treatment access and high discontinuation rates are challenges, as are personalized medication dosing and making timely
Rush AJ, Gore-Langton RE, Bart G, Bradley KA, Campbell CI, McKay J, Oslin DW, Saxon AJ, Winhusen TJ, Wu LT, Moran LM, Tai B.   +11 more
europepmc   +4 more sources

Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule

Addiction Science & Clinical Practice, 2021
Background In the United States, methadone for opioid use disorder (OUD) is limited to highly regulated opioid treatment programs (OTPs), rendering it inaccessible to many patients.
Jordana Laks, Jessica Kehoe, Natalija M. Farrell, Miriam Komaromy, Jonathan Kolodziej, Alexander Y. Walley, Jessica L. Taylor   +6 more
doaj   +1 more source